Heather Hsu, PhD

Chief Scientific Officer

Heather has over 23 years of pharmaceutical/biotech industry experience with research and development. Her PhD in Biological Chemistry from the University of Michigan included a collaboration with Eli Lilly. In the years since, Heather has led pharmacology and nonclinical research teams in indication areas including, cardiovascular and liver diseases at companies including Johnson & Johnson and Gilead Sciences, as well as Calistoga Pharmaceuticals. Her work includes supporting 26 clinical trials with design and clinical pharmacology analysis and regulatory filings including 17 INDs and an NDA.